© 2003 BMJ Publishing Group
EDITORIAL
Industry funding
Chasing the dollar: why scientists should decline tobacco industry funding
R E Malone, L A Bero, University of California, San Francisco, USA
Correspondence to:
Correspondence to:
Ruth E Malone, Department of Social and Behavioral Sciences, School of Nursing and Center for Tobacco Control Research and Education, University of California, San Francisco, Box 1390, UCSF, San Francisco, CA 941431390;
rmalone@itsa.ucsf.edu
Tobacco dollars are a bad bargain
Keywords: conflict of interest; ethics; funding; scientists; tobacco industry
| The first 150 words of the full text of this article appear below. |
Most tobacco researchers now know how the tobacco industry for decades operated clandestinely to obstruct and obfuscate the scientific evidence that smoking causes cancer and, later, that secondhand smoke causes disease in non-smokers. The tobacco industrys internal documents, released as a result of the US states Attorneys General lawsuits and other legal cases, provide ample evidence that is analysed in an expanding body of work.1,2 What may not be as widely known is that these documents also highlight how the industry used respected scientists to advance its goals. Fields and Chapmans important and well documented case study in this issue of the journal shows that even internationally renowned scientists are not immune to the seductions of industry funding.3
What is important for todays scientists to understand is that credibility is perhaps the most desired scientific product for tobacco industry funded research. To illustrate, you need look no further
Relevant Article
- MENTAL HEALTH, UNEMPLOYMENT, TOBACCO, WASTE, AND PIGS
- John R Ashton and Carlos Alvarez-Dardet
J Epidemiol Community Health 2003 57: 545.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Campbell, R. B., Balbach, E. D.
(2009). Building Alliances in Unlikely Places: Progressive Allies and the Tobacco Institute's Coalition Strategy on Cigarette Excise Taxes. Am. J. Public Health
99: 1188-1196
[Abstract] [Full Text] -
Cohen, J E, Zeller, M, Eissenberg, T, Parascandola, M, O'Keefe, R, Planinac, L, Leischow, S
(2009). Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tobacco Control
18: 228-234
[Full Text] -
Derry, R., Waikar, S. V.
(2008). Frames and Filters: Strategic Distrust as a Legitimation Tool in the 50-Year Battle Between Public Health Activists and Big Tobacco. Business Society
47: 102-139
[Abstract] -
Schick, S. F, Glantz, S. A
(2007). Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement. Tobacco Control
16: 157-164
[Abstract] [Full Text] -
McDaniel, P A, Smith, E A, Malone, R E
(2006). Philip Morris's Project Sunrise: weakening tobacco control by working with it. Tobacco Control
15: 215-223
[Abstract] [Full Text] -
Hirschhorn, N, Bialous, S A., Shatenstein, S
(2006). The Philip Morris External Research Program: results from the first round of projects. Tobacco Control
15: 267-269
[Abstract] [Full Text] -
Eissenberg, T
(2006). The time for tobacco industry sponsored PREP evaluation has arrived. Tobacco Control
15: 1-2
[Full Text] -
Bero, L A, Glantz, S, Hong, M-K
(2005). The limits of competing interest disclosures. Tobacco Control
14: 118-126
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
